Page 1

FREDUN PHARMACEUTICALS LIMITED CIN No : L24239MH1987PLC043662 Compassionate Healthcare f Date : 05th August , 2026 To , BSE Limited Listing Department , Phiroze Jeejeebhoy Towers , Dalal Street - Fort , Mumbai 400 001 . Ref .: BSE Scrip Code - 539730 Subject : Outcome of the Board Meeting Dear Sir / Madam , Pursuant to Regulations 30 and 33 of SEBI ( Listing Obligations & Disclosure Requirements ) Regulations , 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday , August 05 , 2026 has inter - alia , considered , adopted and approved following items of business : 1. In compliance to Regulation 30 and 33 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , the Un - Audited Financial Results of the Company for the quarter ended 30th June , 2026 along with the Limited Review Report as issued by M / s . R.H. Nisar & Co , Statutory Auditor of the Company ; copies of which are attached hereunder ; In furtherance to the intimation filed by the Company dated July 30 , 2026 ; the trading window for trading in securities of the Company by insiders closed on July 01 , 2026 till the end of 48 hours after the declaration of outcome of this Board Meeting . The Board Meeting commenced at 10:30 a.m. and concluded at 11:20 a.m. Kindly oblige and take the same on your Records . Thanking you , FOR FREDUN PHARMACEUTICALS LIMITED FREDUN MEDHORA MANAGING DIRECTOR DIN : 01745348 Registered Office : Urmi Estate , 11th Floor , Ganpatrao Kadam Marg , Lower Parel ( W ) , Mumbai - 400013 . Phone No .: 91-22-4031 8111 Fax : 91-22-4031 8133 Factory : 14,15,16 , Zorabian Industrial Complex , Vevoor , Palghar ( E ) , Dist : Palghar - 401 404 . Phone No .: +917045957828 , +917045957829 , +917045957830 , +917045956857 E - Mail : business@fredungroup.com Web : www.fredungroup.com